ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IHR Impact Healthcare Reit Plc

83.30
-0.70 (-0.83%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Impact Healthcare Reit Plc LSE:IHR London Ordinary Share GB00BYXVMJ03 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.70 -0.83% 83.30 82.80 83.00 83.50 81.20 81.20 576,940 16:35:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Real Estate Investment Trust 42.95M 16.89M 0.0408 20.29 343.1M

Impact Healthcare REIT PLC Result of AGM (7789Z)

17/05/2023 4:49pm

UK Regulatory


Impact Healthcare Reit (LSE:IHR)
Historical Stock Chart


From Apr 2023 to Apr 2024

Click Here for more Impact Healthcare Reit Charts.

TIDMIHR

RNS Number : 7789Z

Impact Healthcare REIT PLC

17 May 2023

17 May 2023

Impact Healthcare REIT plc

("Impact" or the "Company")

Result of 2023 Annual General Meeting

The Board of Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, announces that at the Company's 2023 Annual General Meeting held today, all resolutions proposed at the AGM were voted on and passed by a poll by the Company's shareholders and the results of the poll, including the proxy votes received, are set out below.

Resolutions 1 to 12 (inclusive) were proposed as ordinary resolutions and resolutions 13 to 16 (inclusive) were proposed as special resolutions.

 
      Resolution      Votes For*    %         Votes Against   %       Total votes      Total votes      Votes Withheld 
                                                                      validly cast     cast as % of     ** 
                                                                                       issued share 
                                                                                       capital 
      Receive the 
      Annual Report 
      and Financial 
      Statements 
      Year 31 
 1    December 2022   281,210,111   100.00%         0         0.00%    281,210,111         67.86%          226,521 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      Approve the     281,154,070   99.96%       115,981      0.04%    281,270,051         67.88%          166,581 
      directors' 
      remuneration 
 2    report 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      Approve the 
      Company's 
      Dividend 
 3    Policy          281,387,092   100.00%         0         0.00%    281,387,092         67.91%           49,540 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      Re-elect 
      Rosemary Boot 
 4    as a director   278,046,424   98.81%      3,343,574     1.19%    281,389,998         67.91%           46,634 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      Re-elect 
      Philip Hall 
 5    as a director   278,055,966   98.81%      3,334,922     1.19%    281,390,888         67.91%           45,744 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      Re-elect 
      Amanda 
      Aldridge as a 
 6    director        279,416,802   99.30%      1,974,086     0.70%    281,390,888         67.91%           45,744 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      Re-elect 
      Chris Santer 
 7    as a director   279,425,480   99.30%      1,965,408     0.70%    281,390,888         67.91%           45,744 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      Elect Simon 
      Laffin as a 
 8    director        281,388,218   100.00%       2,670       0.00%    281,390,888         67.91%           45,744 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      To re-appoint   276,383,577   100.00%       5,434       0.00%    276,389,011         66.70%         5,047,621 
      BDO LLP as 
      the Company's 
 9    auditor 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      To authorise    281,388,454   100.00%       2,434       0.00%    281,390,888         67.91%           45,744 
      the board of 
      directors to 
      determine the 
      auditors 
 10   remuneration 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      To authorise    281,279,879   99.96%       104,277      0.04%    281,384,156         67.91%           48,680 
      the Directors 
      to allot 
      shares under 
      section 551 
      Companies Act 
 11   2006 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      Subject to      281,251,968   99.95%       138,920      0.05%    281,390,888         67.91%           45,744 
      the passing 
      of resolution 
      11, to 
      authorise the 
      Directors to 
      allot 
      additional 
      shares 
      under section 
      551 Companies 
 12   Act 2006 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      Subject to      280,589,017   99.72%       798,935      0.28%    281,387,952         67.91%           48,680 
      the passing 
      of resolution 
      11, to 
      disapply 
      statutory 
      pre-emption 
      rights under 
      section 
      570 Companies 
 13   Act 2006 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      Subject to      274,009,998   97.38%      7,377,954     2.62%    281,387,952         67.91%           48,680 
      the passing 
      of resolution 
      12, to 
      disapply 
      statutory 
      pre-emption 
      rights under 
      section 
      570 Companies 
 14   Act 2006 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      To authorise    273,102,300   97.07%      8,240,537     2.93%    281,342,837         67.90%           93,795 
      the Company 
      to make 
      market 
      purchase of 
      its own 
      ordinary 
 15   shares 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
      To permit       274,651,335   97.60%      6,739,553     2.40%    281,390,888         67.91%           45,744 
      general 
      meetings to 
      be called on 
      14 days' 
 16   notice 
     --------------  ------------  --------  --------------  ------  ---------------  ---------------  --------------- 
 

Every shareholder has one vote for every Ordinary Share held. As at close of business on 17 May 2023, the share capital of the Company consisted of 414,368,169 Ordinary Shares with voting rights. The Company does not hold any shares in Treasury.

In accordance with Listing Rule 9.6.2, copies of all the resolutions passed, other than ordinary business, will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

* Includes discretionary votes.

** A vote withheld is not a vote in law and is not counted in the calculation of the votes for or against a resolution.

FOR FURTHER INFORMATION, PLEASE CONTACT:

 
 Impact Health Partners LLP             via Maitland/AMO 
  Mahesh Patel 
  Andrew Cowley 
 
 JTC (UK) Limited - Company Secretary   0207 409 0181 
  Susan Fadil                            Impact.CoSec@jtcgroup.com 
 
 Maitland/AMO (Communications           07747 113 930 
  Adviser)                               i mpact health-maitland@maitland.co.uk 
  James Benjamin 
 

The Company's LEI is 213800AX3FHPMJL4IJ53.

NOTES

Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.

The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.

The Company has a progressive dividend policy with a target to grow its annual aggregate dividend in line with the inflation-linked rental uplifts received by the Group under the terms of the rent review provisions contained in the Group's leases in the prior financial year.

On this basis, the target total dividend for the year ending 31 December 2023 is 6.77 pence per share(3) , a 3.53% increase over the 6.54 pence in dividends paid or declared per ordinary share for the year ended 31 December 2022.

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.

(3) This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGARMATMTIBBRJ

(END) Dow Jones Newswires

May 17, 2023 11:49 ET (15:49 GMT)

1 Year Impact Healthcare Reit Chart

1 Year Impact Healthcare Reit Chart

1 Month Impact Healthcare Reit Chart

1 Month Impact Healthcare Reit Chart

Your Recent History

Delayed Upgrade Clock